ARCHIVES

NCI Critics Take Their Best Shots, Seek New Emphasis On Prevention At Kennedy Hearings

This article is from The Cancer Letter archive.

Vol. 05 No. 11 | March 16, 1979

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008

NCI Extramural Programs: NCAB Approves Guidelines for Cancer Center Grants

March 7, 1997